DNMT1 and cancer: Next, our DNMT inhibitor was screened against a panel of different cancer cell lines (KG-1, U-937, RAJI, PC-3, and MDA-MB-231 cells), where it was more potent than SGI-1027 and DAC in impairing cell viability (IC50 values in the low micromolar/submicromolar range).